Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9038837rdf:typepubmed:Citationlld:pubmed
pubmed-article:9038837lifeskim:mentionsumls-concept:C0242692lld:lifeskim
pubmed-article:9038837lifeskim:mentionsumls-concept:C0036226lld:lifeskim
pubmed-article:9038837lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9038837lifeskim:mentionsumls-concept:C0243144lld:lifeskim
pubmed-article:9038837lifeskim:mentionsumls-concept:C0596235lld:lifeskim
pubmed-article:9038837lifeskim:mentionsumls-concept:C0747055lld:lifeskim
pubmed-article:9038837lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:9038837lifeskim:mentionsumls-concept:C0795749lld:lifeskim
pubmed-article:9038837pubmed:issue1 Pt 1lld:pubmed
pubmed-article:9038837pubmed:dateCreated1997-3-28lld:pubmed
pubmed-article:9038837pubmed:abstractTextExperiments were undertaken to study the possibility that the calcium channel blocker D-600 (gallopamil), which penetrates into muscle cells (20), facilitates excitation-contraction coupling in skeletal muscle (7) by a direct effect on the sarcoplasmic reticulum (SR). The effects of D-600 were studied on single phasic muscle fibers, either intact or split open. D-600 potentiated twitches in intact fibers at concentrations lower than those reported in whole muscles. In split fibers, the force produced by caffeine-induced Ca2+ release from the SR was reversibly inhibited by 5 microM D-600, when added to the Ca2+ loading solution. This inhibitory effect was inversely related to temperature, and it was dose dependent. When D-600 was added after Ca2+ loading and before caffeine exposure, or during the caffeine exposure itself, it did not inhibit Ca2+ release, but rather increased the development of force. We conclude that, apart from the blocking effect that D-600 may have on the voltage sensor, the drug penetrates into the myoplasm and affects excitation-contraction coupling by inhibiting the SR Ca2+ pump. This may be the consequence of a conformational change in the transmembrane Ca2+ binding domain of the ATPase.lld:pubmed
pubmed-article:9038837pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9038837pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9038837pubmed:languageenglld:pubmed
pubmed-article:9038837pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9038837pubmed:citationSubsetIMlld:pubmed
pubmed-article:9038837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9038837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9038837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9038837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9038837pubmed:statusMEDLINElld:pubmed
pubmed-article:9038837pubmed:monthJanlld:pubmed
pubmed-article:9038837pubmed:issn0002-9513lld:pubmed
pubmed-article:9038837pubmed:authorpubmed-author:Gonzalez-Serr...lld:pubmed
pubmed-article:9038837pubmed:authorpubmed-author:LepockJ RJRlld:pubmed
pubmed-article:9038837pubmed:authorpubmed-author:OrtegaAAlld:pubmed
pubmed-article:9038837pubmed:issnTypePrintlld:pubmed
pubmed-article:9038837pubmed:volume272lld:pubmed
pubmed-article:9038837pubmed:ownerNLMlld:pubmed
pubmed-article:9038837pubmed:authorsCompleteYlld:pubmed
pubmed-article:9038837pubmed:paginationC310-7lld:pubmed
pubmed-article:9038837pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9038837pubmed:meshHeadingpubmed-meshheading:9038837-...lld:pubmed
pubmed-article:9038837pubmed:meshHeadingpubmed-meshheading:9038837-...lld:pubmed
pubmed-article:9038837pubmed:meshHeadingpubmed-meshheading:9038837-...lld:pubmed
pubmed-article:9038837pubmed:meshHeadingpubmed-meshheading:9038837-...lld:pubmed
pubmed-article:9038837pubmed:meshHeadingpubmed-meshheading:9038837-...lld:pubmed
pubmed-article:9038837pubmed:meshHeadingpubmed-meshheading:9038837-...lld:pubmed
pubmed-article:9038837pubmed:meshHeadingpubmed-meshheading:9038837-...lld:pubmed
pubmed-article:9038837pubmed:meshHeadingpubmed-meshheading:9038837-...lld:pubmed
pubmed-article:9038837pubmed:meshHeadingpubmed-meshheading:9038837-...lld:pubmed
pubmed-article:9038837pubmed:meshHeadingpubmed-meshheading:9038837-...lld:pubmed
pubmed-article:9038837pubmed:meshHeadingpubmed-meshheading:9038837-...lld:pubmed
pubmed-article:9038837pubmed:meshHeadingpubmed-meshheading:9038837-...lld:pubmed
pubmed-article:9038837pubmed:meshHeadingpubmed-meshheading:9038837-...lld:pubmed
pubmed-article:9038837pubmed:year1997lld:pubmed
pubmed-article:9038837pubmed:articleTitleEffect of the organic Ca2+ channel blocker D-600 on sarcoplasmic reticulum Ca2+ uptake in skeletal muscle.lld:pubmed
pubmed-article:9038837pubmed:affiliationDepartment of Physiology, University of Maryland, Baltimore 21201, USA.lld:pubmed
pubmed-article:9038837pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9038837pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9038837pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed